Kinetics of Fibrinopeptide Release by Thrombin as a Function of CaCl 2 Concentration: Different Susceptibility of FPA and FPB and Evidence for a Fibrinogen Isoform-Specific Effect at Physiological Ca 2+ Concentration

Biochemistry

Volumn 42, Issue 42, 2003, Pages 12335-12348

  Profumo, Aldo ^a   Turci, Marco ^a   Damonte, Gianluca ^b   Ferri, Fabio ^c   Magatti, Davide ^c   Cardinali, Barbara ^c   Cuniberti, Carla ^b   Rocco, Mattia ^a,d  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF INSUBRIA   (Italy)

^d CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM COMPOUNDS; CORRELATION METHODS; IONIC STRENGTH; PH EFFECTS; PROTEINS; RATE CONSTANTS;

POLYDISPERSITY;

BIOCHEMISTRY;

BINDING PROTEIN; BUFFER; CALCIUM; CALCIUM CHLORIDE; CHLORIDE; EDETIC ACID; FIBRINOGEN; FIBRINOPEPTIDE; FIBRINOPEPTIDE A; FIBRINOPEPTIDE B; ISOPROTEIN; SODIUM; SODIUM CHLORIDE; THROMBIN;

ALPHA CHAIN; ARTICLE; BETA CHAIN; CALCULATION; CARBOXY TERMINAL SEQUENCE; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; DEPLETION; DISPERSION; FIBRIN FORMATION; GROWTH; HUMAN; IONIC STRENGTH; PARAMETER; PH; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN STRUCTURE; TECHNIQUE; TRANSPORT KINETICS; WESTERN BLOTTING;

CALCIUM; CALCIUM CHLORIDE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBRINOPEPTIDE A; FIBRINOPEPTIDE B; HUMANS; KINETICS; THROMBIN;

EID: 0142063416     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi034411e     Document Type: Article

References (83)

1. Doolittle, R. F. (2000) The molecular basis of fibrin, in The Molecular Basis of Blood Diseases (Stamatoyannopoulos, G., Majerus, P. W., Perlmutter, R. M., and Varmus, H., Eds.) 3rd ed., pp 719-739, Saunders, Philadelphia.
2. Blomback, B. (1996) Fibrinogen and fibrin: proteins with complex roles in hemostasis and thrombosis, Thromb. Res. 83, 1-75.
3. Doolittle, R. F. (1984) Fibrinogen and fibrin, Annu. Rev. Biochem. 53, 195-229.
4. Mosesson, M. W., and Doolittle, R. F., Eds. (1983) Molecular Biology of Fibrinogen and Fibrin, Annals of the New York Academy of Sciences Vol. 406, New York Academy of Sciences, New York.
5. Yee, V. C., Pratt, K. P., Cote, H. C. F., Letrong, I., Chung, D. W., Davie, E. W., Stenkamp, R. E., and Teller, D. C. (1997) Crystal structure of a 30 kDa C-terminal fragment from the γ-chain of human fibrinogen, Structure 5, 125-138.
6. Spraggon, G., Everse, S. J., and Doolittle, R. F. (1997) Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin, Nature 389, 455-462.
7. Brown, J. H., Volkmann, N., Henschen-Edman, A. H., and Cohen, C. (2000) The crystal structure of modified bovine fibrinogen, Proc. Natl. Acad. Sci. U.S.A. 97, 85-90.
8. Yang, Z., Kollman, J. M., Pandi, L., and Doolittle, R. F. (2001) Crystal structure of native chicken fibrinogen at 2.7 Å resolution, Biochemistry 40, 12515-12523.
9. Mosesson, M. W., Hainfeld, J., Wall, J., and Haschemeyer, R. H. (1981) Identification and mass analysis of human fibrinogen molecules and their domains by scanning transmission electron microscopy, J. Mol. Biol. 153, 695-718.
10. Medved', L. V., Gorkun, O. V., and Privalov, P. L. (1983) Structural organization of C-terminal parts of fibrinogen Aα-chains, FEBS Lett. 160, 291-295.
11. Erickson, H. P., and Fowler, W. E. (1983) Electron microscopy of fibrinogen, its plasmic fragments and small polymers, in Molecular Biology of Fibrinogen and Fibrin (Mosesson, M. W., and Doolittle, R. F., Eds.) Annals of the New York Academy of Sciences Vol. 406, pp 146-163, New York Academy of Sciences, New York.
12. Weisel, J. W., Stauffacher, C. V., Bullit, T. E., and Cohen, C. (1985) A model for fibrinogen: domains and sequence, Science 230, 1388-1391.
13. Veklich, Y. I., Gorkun, O. V., Medved, L. V., Nieuwenhuizen, W., and Weisel, J. W. (1993) Carboxyl-terminal portions of the α chains of fibrinogen and fibrin. Localization by electron microscopy and the effects of isolated αC fragments on polymerization, J. Biol. Chem. 268, 13577-13585.
14. Mosesson, M. W. (1983) Fibrinogen heterogeneity, in Molecular Biology of Fibrinogen and Fibrin (Mosesson, M. W., and Doolittle, R. F., Eds.) Annals of the New York Academy of Sciences Vol. 406, pp 97-113, New York Academy of Sciences, New York.
15. Henschen-Edman, A. (2001) Fibrinogen non-inherited heterogeneity and its relationship to function in health and disease, in Fibrinogen. XVIth International Fibrinogen Workshop (Nieuwenhuizen, W., Mosesson, M. W., and De Maat, P. M., Eds.) Annals of the New York Academy of Sciences Vol. 936, pp 580-593, New York Academy of Sciences, New York.
16. Di Cera, E., Dang, Q. D., and Ayala, Y. M. (1997) Molecular mechanisms of thrombin function, Cell. Mol. Life Sci. 53, 701-730.
17. Hurlet-Jensen, A., Cummins, H. Z., Nossel, H. L., and Liu, C. Y. (1982) Fibrin polymerization and release of fibrinopeptide B by thrombin, Thromb. Res. 27, 419-427.
18. Weisel, J. W. (1986) Fibrin assembly. Lateral aggregation and the role of the two pairs of fibrinopeptides, Biophys. J. 50, 1079-1093.
19. Yang, Z., Mochalkin, I., and Doolittle, R. F. (2000) A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides, Proc. Natl. Acad. Sci. U.S.A. 97, 14156-14161.
20. Janmey, P. A. (1982) Kinetics of formation of fibrin oligomers. I. Theory, Biopolymers 21, 2253-2264.
21. Bernocco, S., Ferri, F., Profumo, A., Cuniberti, C., and Rocco, M. (2000) Polymerization of rod-like macromolecular monomers studied by stopped-flow, multi-angle light scattering: set-up, data processing, and application to fibrin formation, Biophys. J. 79, 561-583.
22. Shainoff, J. R., Smejkal, G. B., DiBello, P. M., Mitkevich, O. V., Levy, P. J., Dempfle, C. E., and Lill, H. (1996) Isolation and characterization of the fibrin intermediate arising from cleavage of one fibrinopeptide A from fibrinogen, J. Biol. Chem. 271, 24129-24137.
23. Shainoff, J. R., Smejkal, G. B., DiBello, P. M., Sung, S. S., Bush, L. A., and Di Cera, E. (2002) Allosteric effects potentiating the release of the second fibrinopeptide A from fibrinogen by thrombin, J. Biol. Chem. 277, 19367-19373.
24. Li, X., Galanakis, D., and Gabriel, D. A. (1996) Transient intermediates in the thrombin activation of fibrinogen: Evidence for only the desAA species, J. Biol. Chem. 271, 11767-11771.
25. Meh, D. A., Siebenlist, K. R., Bergtrom, G., and Mosesson, M. W. (1995) Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin, J. Lab. Clin. Med. 125, 384-391.
26. Shainoff, J. R., Ratnoff, O. D., Smejkal, G. B., DiBello, P. M., Welches, W. R., Lill, H., Mitkevich, O. V., and Periman, P. (2001) Confirmation of Mendelian properties of heterodimeric fibrinogen molecules in a heterozygotic dysfibrinogenemia, "fibrinogen Amarillo", using GPRphoresis to differentiate semifibrin molecules from fibrinogen and fibrin, Thromb. Res. 101, 91-99.
27. Costantini, V., and Zacharski, L. R. (1992) The role of fibrin in tumor metastasis, Cancer Metastasis Rev. 11, 283-290.
28. Nagy, J. A., Brown, L. F., Senger, D. R., Lanir, N., Van De Water, L., Dvorak, A. M., and Dvorak, H. F. (1988) Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition, Biochim. Biophys. Acta 948, 305-326.
29. Rickles, F. R., Levine, M., and Edwards, R. L. (1992) Hemostatic alterations in cancer patients, Cancer Metastasis Rev. 11, 237-248.
30. Milroy, R., Douglas, J. T., Campbell, J., Carter, R., Lowe, G. D., and Banham, S. W. (1988) Abnormal haemostasis in small cell lung cancer, Thorax 43, 978-981.
31. Korte, W. (2000) Changes of the coagulation and fibrinolysis system in malignancy: their possible impact on future diagnostic and therapeutic procedures, Clin. Chem. Lab. Med. 38, 679-692.
32. van Ruijven-Vermeer, I. A. M., Nieuwenhuizen, W., and Nooijen, W. J. (1978) Ca binding of rat fibrinogen and fibrin(ogen) degradation products, FEBS Lett. 93, 177-180.
33. Nieuwenhuizen, W., Vermond, A., Nooijen, W. J., and Haverkate, F. (1979) Calcium-binding properties of human fibrin(ogen) and degradation products, FEBS Lett. 98, 257-259.
34. Nieuwenhuizen, W., van Ruijven-Vermeer, I. A. M., Nooijen, W. J., Vermond, A., Haverkate, F., and Hermans, J. (1981) Recalculation of calcium-binding properties of human and rat fibrin(ogen) and their degradation products, Thromb. Res. 22, 653-657.
35. Nieuwenhuizen, W., and Haverkate, F. (1983) Calcium-binding regions in fibrinogen, in Molecular Biology of Fibrinogen and Fibrin (Mosesson, M. W., and Doolittle, R. F., Eds.) Annals of the New York Academy of Sciences Vol. 406, pp 92-96, New York Academy of Sciences, New York.
36. Marguerie, G., Chagniel, G., and Suscillon, M. (1977) The binding of calcium to bovine fibrinogen, Biochim. Biophys. Acta 490, 94-103.
37. Everse, S. J., Spraggon, G., Veerapandian, L., Riley, M., and Doolittle, R. D. (1998) Crystal structure of fragment double-D from human fibrin with two different bound ligands, Biochemistry 37, 8637-8642.
38. Everse, S. J., Spraggon, G., Veerapandian, L., and Doolittle, R. D. (1999) Conformational changes in fragments D and double-D from human fibrin(ogen) upon binding the peptide ligand Gly-His-Arg-Pro-amide, Biochemistry 38, 2941-2946.
39. Kostelansky, M. S., Betts, L., Gorkun, O. V., and Lord, S. T. (2002) 2.8 Å crystal structures of recombinant fibrinogen fragment D with and without two peptide ligands: GHRP binding to the "b" site disrupts its nearby calcium-binding site, Biochemistry 41, 12124-12132.
40. Dang, C. V., Shin, C. K., Bell, W. R., Nagaswami, C., and Weisel, J. W. (1989) Fibrinogen sialic acid residues are low affinity calcium-binding sites that influence fibrin assembly, J. Biol. Chem. 264, 15104-15108.
41. Marguerie, G. (1977) The binding of calcium to fibrinogen: some structural features, Biochim. Biophys. Acta 494, 172-181.
42. Marguerie, G., and Ardaillou, N. (1982) Potential role of the Aα chain in the binding of calcium to human fibrinogen, Biochim. Biophys. Acta 701, 410-412.
43. Haverkate, F., and Timan, G. (1977) Protective effect of calcium in the plasmin degradation of fibrinogen and fibrin fragments D, Thromb. Res. 10, 803-812.
44. Shen, L. L., McDonagh, R. P., McDonagh, J., and Hermans, J., Jr. (1974) Fibrin gel structure: influence of calcium and covalent cross-linking on the elasticity, Biochem. Biophys. Res. Commun. 56, 793-798.
45. Okada, M., and Blomback, B. (1983) Calcium and fibrin gel structure, Thromb. Res. 29, 269-280.
46. Mihalyi, E. (1988) Clotting of bovine fibrinogen. Calcium binding to fibrin during clotting and its dependence on release of fibrinopeptide B, Biochemistry 27, 967-976.
47. Martinelli, R. A., and Scheraga, H. A. (1980) Steady-state kinetic study of bovine thrombin-fibrinogen interaction, Biochemistry 19, 2343-2350.
48. Higgins, D. L., Lewis, S. D., and Shafer. J. A. (1983) Steady-state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin, J. Biol. Chem. 258, 9276-9282.
49. Hanna, L. S., Scheraga, H. A., Francis, C. W., and Marder, V. J. (1984) Comparison of structures of various human fibrinogens and a derivative thereof by a study of the kinetics of release of fibrinopeptides, Biochemistry 23, 4681-4687.
50. Mihalyi, E. (1988) Clotting of bovine fibrinogen. Kinetic analysis of the release of fibrinopeptides by thrombin and of the calcium uptake upon clotting at high fibrinogen concentrations, Biochemistry 27, 976-982.
51. Vindigni, A., and Di Cera, E. (1996) Release of fibrinopeptides by the slow and fast forms of thrombin, Biochemistry 35, 4417-4426.
52. Rocco, M., Bernocco, S., Turci, M., Profumo, A., Cuniberti, C., and Ferri, F. (2001) Early events in the polymerization of fibrin, in Fibrinogen. XVIth International Fibrinogen Workshop (Nieuwenhuizen, W., Mosesson, M. W., and De Maat, P. M., Eds.) Annals of the New York Academy of Sciences Vol. 936, pp 167-185, New York Academy of Sciences, New York.
53. Ferri, F., Greco, M., Arcòvito, G., Andreasi Bassi, F., De Spirito, M., Paganini, E., and Rocco, M. (2001) Growth kinetics and structure of fibrin gels, Phys. Rev. E 63, 031401-1/17.
54. Ferri, F., Greco, M., Arcòvito, G., De Spirito, M., and Rocco, M. (2002) Structure of fibrin gels studied by elastic light scattering techniques: dependence of fractal dimension, gel crossover length, fiber diameter and fiber density on monomer concentration, Phys. Rev. E 66, 011913-1/13.
55. Mihalyi, M. (1968) Physicochemical studies of bovine fibrinogen. IV. Ultraviolet absorption and its relation to the structure of the molecule, Biochemistry 7, 208-223.
56. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227, 680-685.
57. Koppert, P. W., Huijsmans, C. M. G., and Nieuwenhuizen, W. (1985) A monoclonal antibody, specific for human fibrinogen, fibrinopeptide A-containing fragments and not reacting with free fibrinopeptide A, Blood 66, 503-507.
58. Fornace, A. J., Jr., Cummings, D. E., Comeau, C. M., Kant, J. A., and Crabtree, G. R. (1984) Structure of the human γ-fibrinogen gene. Alternate mRNA splicing near the 3′ end of the gene produces γA and γB forms of γ-fibrinogen, J. Biol. Chem. 259, 12826-12830.
59. Shiba, E., Lindon, J. N., Kushner, L., Matsueda, G. R., Hawiger, J., Kloczewiak, M., Kudryk, B., and Salzman, E. W. (1991) Antibody-detectable changes in fibrinogen adsorption affecting platelet activation on polymer surfaces. Am. J. Physiol. 260, C965-C974.
60. Haidaris, P. J., Francis, C. W., Sporn, L. A., Arvan, D. S., Collichio, F. A., and Marder, V. J. (1989) Megakaryocyte and hepatocyte origins of human fibrinogen biosynthesis exhibit hepatocyte-specific expression of γ chain-variant polypeptides, Blood 74, 743-750.
61. Haidaris, P. J., Peerschke, E. I. B., Marder, V. J., and Francis, C. W. (1989) The C-terminal sequences of the γ57.5 chain of human fibrinogen constitute a plasmin sensitive epitope that is exposed in crosslinked fibrin, Blood 74, 2437-2444.
62. Lottenberg, R., Christensen, U., Jackson, C. M., and Coleman, P. L. (1981) Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates, Methods Enzymol. 80, 341-361.
63. Kehl, M., Lottspeich, F., and Henschen, A. (1981) Analysis of human fibrinopeptides by high-performance liquid chromatography, Hoppe-Seyler's Z. Physiol. Chem. 362, 1661-1664.
64. Bevington, P. R. (1991) Data reduction and error analysis for the physical sciences, McGraw-Hill, New York.
65. +-ATPase measured by fluorescent quenching, Biophys. Chem. 69, 137-151.
66. Metzler, R., Klafter, J., Jortner, J., and Volk, M. (1998) Multiple time scales for dispersive kinetics in early events of peptide folding, Chem. Phys. Lett. 293, 477-484.
67. Takagi, T., and Doolittle, R. F. (1975) Amino acid sequence studies on the α-chain of human fibrinogen. Location of four plasmin attack points and a covalent cross-linking site, Biochemistry 14, 5149-5155.
68. Cottrell, B. A., and Doolittle, R. F. (1976) The amino acid sequence of a 27-residue peptide released from the α-chain carboxy-terminus during the plasmic digestion of human fibrinogen, Biochem. Biophys. Res. Commun. 71, 754-761.
69. Strong, D. D., Watt, K. W., Cottrell, B. A., and Doolittle, R. F. (1979) Amino acid sequence studies on the α-chain of human fibrinogen. Complete sequence of the largest cyanogen bromide fragment, Biochemistry 18, 5399-5404.
70. Watt, K. W., Cottrell, B. A., Strong, D. D., and Doolittle, R. F. (1979) Amino acid sequence studies on the α-chain of human fibrinogen. Overlapping sequences providing the complete sequence, Biochemistry 18, 5410-5416.
71. Nakashima, A., Sasaki, S., Miyazaki, K., Miyata, T., and Iwanaga, S. (1992) Human fibrinogen heterogeneity: the COOH-terminal residues of defective Aα chains of fibrinogen II, Blood Coagulation Fibrinolysis 3, 361-370.
72. Tsurupa, G., Tsonev, L., and Medved, L. (2002) Structural organization of the fibrin(ogen) αC-domain, Biochemistry 41, 6449-6459.
73. Meh, D. A., Siebenlist, K. R., and Mosesson, M. W. (1996) Identification and characterization of the thrombin binding sites on fibrin, J. Biol. Chem. 271, 23121-23125.
74. Meh, D. A., Mosesson, M. W., Siebenlist, K. R., Simpson-Haidaris, P. J., Brennan, S. O., DiOrio, J. P., Thompson, K., and Di Minno, G. (2001) Fibrinogen Naples I (Bβ A68T) nonsubstrate thrombin-binding capacities, Thromb. Res. 103, 63-73.
75. Meh, D. A., Siebenlist, K. R., Brennan, S. O., Holyst, T., and Mosesson, M. W. (2001) The amino acid sequence in fibrin responsible for high affinity thrombin binding, Thromb. Haemostasis 85, 470-474.
76. Moaddell, M., Falls, L. A., and Farrell, D. H. (2000) The role of γA/γ′ fibrinogen in plasma factor XIII activation, J. Biol. Chem. 275, 32135-32140.
77. Lovely, R. S., Falls, L. A., Al-Mondhiry, H. A., Chambers, C. E., Sexton, G. J., Ni, H., and Farrell, D. H. (2002) Association of γA/ γ′ fibrinogen levels and coronary artery disease, Thromb. Haemostasis 88, 26-31.
78. Homyak, T. J., Bishop, P. D., and Shafer, J. A. (1989) α-Thrombin-catalyzed activation of human platelet Factor XIII: relationship between proteolysis and Factor XIIIa activity, Biochemistry 28, 7326-7332.
79. Gorkun, O. V., Veklich, Y. I., Medved, L. V., Henshen, A. H., and Weisel, J. W. (1994) Role of the αC domains of fibrin in clot formation, Biochemistry 33, 6986-6997.
80. Madrazo, J., Brown, J. H., Litvinovich, S., Dominguez, R., Yakovlev, S., Medved, L., and Cohen, C. (2001) Crystal structure of the central region of bovine fibrinogen (E5 fragment) at 1.4-Å resolution, Proc. Natl. Acad. Sci. U.S.A. 98, 11967-11972.
81. Moaddel, M., Farrell, D. H., Daugherty, M. A., and Fried, M. G. (2000) Interactions of human fibrinogens with factor XIII: Roles of calcium and the γ′ peptide, Biochemistry 39, 6698-6705.
82. Cooper, A. V., Standeven, K. F., and Ariens, R. A. S. (2003) Fibrinogen γ-chain splice variant γ′ alters fibrin formation and structure, Blood 102, 535-540.
83. Mullin, J. L., Gorkun, O. V., Binnie, C. G., and Lord, S. T. (2000) Recombinant fibrinogen studies reveal that thrombin specificity dictates order of fibrinopeptide release, J. Biol. Chem. 275, 25239-25246.